-
Mashup Score: 1Highlights from ESMO WCGIC 2022 - 2 year(s) ago
Jonathan Strickler, MD, Duke Cancer Institute, Durham, NC, discusses some of the highlights from the ESMO WCGIC 2022 congress, including…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Diagnostic challenges for cholangiocarcinoma - 2 year(s) ago
Lorenza Rimassa, MD, Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy, discusses the challenges of diagnosing bile duct cancer,…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Jonathan Strickler, MD, Duke Cancer Institute, Durham, NC, gives an update on the Phase II MOUNTAINEER trial (NCT03043313), which investigated…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Treatment landscape for cholangiocarcinoma - 2 year(s) ago
Lorenza Rimassa, MD, IRCCS Humanitas Research Hospital, Milan, Italy, explains the basics of cholangiocarcinoma, including the incidence, survival rates, and…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
🎥 John Strickler of @DukeCancer discusses the highlights from ESMO WCGIC 2022 Watch: 👉https://t.co/AjSPC0cL49👈 @myESMO @ESMOWorldGI #WCGIC22 #CRCsm #ColorectalCancer